mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.43 |
0.008 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.01 |